GLUTAONE INJ. 1200 mg
359. GLUTAONE INJ. 1200 mg For bright and smooth skin. It is a ski
Description
GLUTAONE INJ. 1200 mg contains reduced glutathione (GSH) — a tripeptide of glycine, glutamic acid, and cysteine — at a therapeutic 1,200 mg dose formulated for intravenous administration. Glutathione inhibits tyrosinase activity, reducing melanin synthesis and delivering measurable skin brightening, while simultaneously acting as a potent antioxidant that neutralizes reactive oxygen species and supports hepatic detoxification pathways. Indications include hyperpigmentation, melasma, post-inflammatory discolouration, and systemic oxidative load.
Indication
Listed in the Injections product category for the Lumière B2B wholesale catalogue. Intended for distribution to licensed professionals operating in jurisdictions where this product class is approved.
Packaging
Packaging: 359. GLUTAONE INJ. 1200 mg For bright and smooth skin. It is a ski.
Protocol
Administer 1,200 mg IV slow push or diluted in 100 mL normal saline over 15–30 minutes, once to twice weekly using a 23–25G butterfly or IV cannula. A standard brightening course is 8–12 sessions; maintenance is monthly thereafter. Monitor for signs of sulphur sensitivity; do not co-administer with oxidising agents in the same line.
Related Products
#341
CINDELLA INJ.
5 mL x 10 vials, Thioctic acid 25mg
![CINDELLA SET [1200mg]](/_next/image?url=https%3A%2F%2Faxamhqgapwguurisgvvi.supabase.co%2Fstorage%2Fv1%2Fobject%2Fpublic%2Fproduct-images%2Fproduct-340%2F1780970380847.webp&w=3840&q=75)
#340
CINDELLA SET [1200mg]
25 mg / 5 Ml, VITAMIN C 10g / 20 mL / 10 vials De - age De - TOX Whitening injection
#332
MENNUS PLA 200 MG
200 MG 200 mg / vial, porosity PLA (microparticle of polyethylene
#333
MENNUS PLLA 360 MG
36 0 MG PL L A(Poly L - L actic Acid) + CMC(Carboxymethyl celulose)